How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
about
Structural basis of substrate discrimination and integrin binding by autotaxinCrystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptideSerpins flex their muscle: II. Structural insights into target peptidase recognition, polymerization, and transport functionsFunctional structure of the somatomedin B domain of vitronectinCrystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor XThe N terminus of the serpin, tengpin, functions to trap the metastable native stateAn overview of the serpin superfamilyCorticosteroid-binding globulin, a structural basis for steroid transport and proteinase-triggered releaseSolution structure of recombinant somatomedin B domain from vitronectin produced inPichia pastorisCrystal structures of two human vitronectin, urokinase and urokinase receptor complexesHigh-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: A new tool for detailed interaction studies and modelingStructural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1Crystal Structure of Plasminogen Activator Inhibitor-1 in an Active Conformation with Normal Thermodynamic StabilityCrystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signalingCharacterization of a Small Molecule Inhibitor of Plasminogen Activator Inhibitor Type 1 That Accelerates the Transition into the Latent ConformationIdentification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migrationAssignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasmaShear stress-induced Ets-1 modulates protease inhibitor expression in microvascular endothelial cellsVitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.Inhibition of plasminogen activator inhibitor-1 binding to endocytosis receptors of the low-density-lipoprotein receptor family by a peptide isolated from a phage display library.Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region.Cyr61/CCN1 displays high-affinity binding to the somatomedin B(1-44) domain of vitronectin.Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodelingTopology of the disulfide bonds in the antiviral lectin scytovirin.Serpin latency transition at atomic resolutionPancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.Identification and therapeutic potential of a vitronectin binding region of meningococcal msfComputational survey of peptides derived from disulphide-bonded protein loops that may serve as mediators of protein-protein interactionsAbrogation of plasminogen activator inhibitor-1-vitronectin interaction ameliorates acute kidney injury in murine endotoxemia.Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.Effects of extracellular DNA on plasminogen activation and fibrinolysis.Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity.Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progressionVitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophagesA PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathySerpins in thrombosis, hemostasis and fibrinolysisEffects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.
P2860
Q24337236-BA6BB5B9-A331-4061-A074-FC6846653978Q24529128-3BCF5AC7-1F1C-43BF-9EE0-E850AFE7F2AAQ24597208-2D0D41EC-2663-4C69-9EF0-A4B17109D9E7Q24648799-434C7BED-1A2D-4885-A11B-54DEBE36048FQ24649076-75D4B5A0-97B2-4695-8B60-D785B9B29B9CQ24681654-C6888ACD-735C-4680-B96A-B2250A810690Q24684030-A7E23BE4-08DC-456A-92E3-F3ECDEE2B6BEQ27646847-ADD28FB0-C96F-447D-8328-1B82AF97BACAQ27647777-F3619DF8-80A5-4714-A7C3-337764D6FF49Q27650194-A693F1E0-D435-4630-8665-ABDBE69AFDAFQ27651791-4A7C0AB4-AB58-416F-A451-70A75D310A99Q27666429-846226B4-8992-45D2-AA14-3965ED36814CQ27670512-A5197D95-B151-4DB2-A530-4EF70042C2BFQ27673871-9BD4B793-BAF1-4920-A381-5F0A576D6BCAQ27675149-7290755B-9E3B-40C9-9829-A333EABF65C9Q27681464-727A3F26-E606-4031-9CF6-A8EEACAF64A7Q28259956-C2D7FFD9-61A6-49FC-A2C3-BDC8EE841BA0Q28264463-11213836-023F-43B7-8B89-AFA0FF5E7283Q28565567-7D4098BF-609F-45E9-8C07-D96BFE10390FQ30847150-0F258BB6-351A-4484-8297-1BE802A79CC3Q33248476-A9AC057D-095A-441A-886E-32AA0FC3A960Q33278178-01598AB2-9624-48A9-8275-F21D6CD4FE2EQ33535842-4EEFE254-DEFA-4DCB-9D0D-567729312857Q33663388-1F6D1673-5E27-46C1-9429-4B9ED0A061B4Q34122347-9B4D789C-651A-44D7-9FD2-0872CA1CEBB6Q34442472-D201F786-5741-4DEF-A01A-8F0507FF3B46Q35130515-AB4DAA6A-6CE0-4333-B735-126E5C8B7012Q35156659-86FFBCC9-82AA-4009-872C-B850F533D261Q35235006-425FD6EC-0557-4762-878B-5C617A18BD2CQ35260240-7626EAF5-928E-4E56-AECE-407E532AEC45Q35584207-A9E4127B-369B-486A-BEFD-3E25A3980CB5Q35597239-1CC93211-FC4D-4CB7-BAED-0F0050205934Q35605044-42E77CE3-B350-494B-9609-24C50D8CE947Q35688843-180F3F17-27EB-42AE-9EBE-690C2B0A8E90Q36162638-D4C45980-242A-4B73-AFFD-998A2DB98499Q36399256-85348754-FA97-4165-AD70-6A28B94B7EC2Q36625153-075574AE-D862-48E6-B4D7-1E9ABC5138BAQ36677370-4D437CD4-9A8E-4FA2-A736-5A5D7390491BQ36884340-3E943CD1-F54F-42B8-802A-3CF2903F51A9Q36908409-27C40858-E26F-4E22-86A8-27DA178AE2FE
P2860
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@ast
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@en
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@nl
type
label
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@ast
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@en
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@nl
prefLabel
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@ast
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@en
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@nl
P2093
P3181
P356
P1476
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
@en
P2093
James A Huntington
Navraj S Pannu
Robin W Carrell
P304
P3181
P356
10.1038/NSB943
P407
P577
2003-07-01T00:00:00Z